This study not only elucidates the complex interplay between LINC00511, YTHDF2, and SOX2 but also proposes potential therapeutic targets within this regulatory axis for cholangiocarcinoma treatment. This evidence concerns the gene YTHDF2 and cholangiocarcinoma.